6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Quarterly Activities Report - March 2026
Just now	Appendix 4C and Quarterly Activities Report - March 2026
26m ago	Landis+Gyr Announces Sale of Rhebo to Everfield
26m ago	Lazard to Acquire Campbell Lutyens, Creating the Global Leader in Private Capital Advisory
36m ago	2026 ESMO GC \| Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations

About

Inmune Bio Inc (NASDAQ:INMB) — investor relations, events, news, and company updates on 6ix.

Latest News

INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models

INmune Bio Inc. Announces 2025 Results and Provides Business Update

INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.

INmune Bio’s MINDFuL Trial Featured at AD/PD 2026 Plenary as Successful Example of How to Approach Clinical Trials Targeting Inflammation in Early Alzheimer’s Disease

INmune Bio to Detail XPro1595 Registrational Strategy in Upcoming Alzheimer’s Webinar

Financials

Revenue

$50 K

Market Cap

$34.03 M

EPS

-1.86

Community Chat

Ask AI